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Background: Surgical removal of mandibular third molars results in some degree of post-operative pain, swelling 
and trismus. These can be controlled by proper administration of local anesthesia, careful bone removal, minimal 
trauma to adjacent soft tissues and administration of methylprednisolone and serratiopeptidase drugs. The aim of 
the present study was to compare the efficacy of methylprednisolone and serratiopeptidase in controlling post-
operative pain, swelling and trismus after surgical removal of impacted mandibular third molars.
Material and Methods: The subjects were divided into two groups of 50 patients each undergoing surgical removal 
of mandibular third molars.  Group A was given methylprednisolone 4mg orally every 8th hourly and Group B was 
given serratiopeptidase 10 mg every 12th hourly orally.  Post-operatively pain, swelling and trismus were evaluated 
at the end of 1st, 3rd and 5thday.
Results: The results of this study showed that methylprednisolone is an effective analgesic, while serratiopeptidase 
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Introduction
Surgical removal of teeth in oral surgery inevitably re-
quires bone removal, which sometimes results in some 
degree of post-operative pain, swelling and trismus. Mi-
nimal trauma to adjacent soft tissues and proper wound 
closure minimizes pain, swelling and trismus. These can 
be controlled by proper administration of local anesthe-
sia, good flap reflection, careful bone removal and mi-
nimal trauma to adjacent soft tissues with appropriate 
wound closure techniques (1). Pharmacologic strategies 
for minimizing the clinical manifestations of surgical 
injury are therefore, logically directed at blocking the 
formation or inhibiting the effects of mediators of acute 
inflammation. Corticosteroids are routinely employed 
to control the sequelae of inflammation in third molar 
surgeries (2). The effectiveness of glucocorticoids as 
anti-inflammatory  agents was first reported by Hench 
and Kendallin 1949, using cortisone to treat rheumatoid 
arthritis. Steroids act by suppression of leukocyte and 
macrophage accumulation at the inflammatory site by 
interfering with capillary dilatation, fibrin deposition 
and prevention of prostaglandin synthesis by inhibiting 
the arachidonic acid cascade (1-4). 
In a study conducted by Elhag et al. for establishing 
the anti-inflammatory effect of methylprednisolone, the 
author found that the methylprednisolone group had 
mean swelling volumes significantly lower than that of 
the control (5). A study conducted by Akhan has sug-
gested that, the pre-operative use of methylprednisolone 
appears to be a safe and effective method of reducing 
post-operative complications in third molar surgery (6). 
Al-Khateeb and Nusair on the use of serratiopeptidase 
for reduction of post operative pain, swelling and tris-
mus after third molar surgery, concluded that significant 
reduction in swelling could be achieved with the use of 
serratiopeptidase (7).
Since very few researchers studied the efficacy of me-
thylprednisolone and serratiopeptidase in postoperative 
management pain, swelling and trismus; very limited 
information was available in the literature regarding 
these two drugs and so far no comparative studies are 
available on methylprednisolone and serratiopeptidase 
in reduction of postoperative sequelae after third molar 
surgery. Hence an attempt has been made to study the 
efficacy of these two drugs in patients undergoing surgi-
cal extraction of third molar.
has moderate analgesic activity. Serratiopeptidase is more effective than methylprednisolone in controlling post sur-
gical swelling and trismus. Hence combination of these two drugs would be very effective than individual drug when 
widespread post-operative sequelae are expected after surgical removal of impacted lower third molars.
Conclusions: We conclude that methylprednisolone affords better pain relief while serratiopeptidase exerts better 
anti-inflammatory and anti-swelling effects in the post-operative period. Synergistic combinations of these two drugs 
would however prove to be more effective when extensive post-operative sequelae are expected.
Key words: Methylprednisolone, serratiopeptidase, pain, swelling, trismus, third molar.
Material and Methods 
Present study was carried out on 100 patients on an out-
patient basis in the department of oral and maxillofa-
cial surgery. Patients were divided randomly into two 
groups, irrespective of age and sex - each group consis-
ting of 50 patients.
Inclusion criteria included ASA Grade-1 patients and 
absence of pathologic changes teeth and surrounding 
tissues. 
-Exclusion criteria includes;
• Patients with genetically transmitted bleeding disorder
• Extraoral and intraoral swelling with cellulitis in the 
area of surgery
• History of  systemic illness 
• Patient on other  drugs such as NSAIDS and Steroids 
A written consent was obtained from all the pateints 
after being explained about the study purpose and the 
nature of the surgical procedure performed and drugs 
prescribed after it. Ethical clearance was obtained from 
the institutional ethical committee. Pre-operative in-
vestigations which included a complete hemogram and 
serology in all the subjects. Patients who satisfied the 
inclusion and exclusion criteria were taken up for 3rd 
molar extraction  under local anesthesia. Methylpredni-
solone 4mg orally 8th hourly for 5 day was post operati-
vely prescribed to patients in  Group-A while  Group-B 
was prescribed with serratiopeptidase 10mg orally 12th 
hourly for 5 days. The patients were recalled for a follow 
– up visit on 1st, 3rd and 5th day post-operatively.
Pre-operative facial measurements were obtained by 
marking 5 points on the face i.e. at the symphysis, mas-
toid, angleof mandible, lateral canthus of eye and the ala 
of nose. Measurements were taken from a point on the 
angle of mandible which served as a common point, to 
the tragus, lateral canthus of eye, ala of the nose, angle 
of the mouth and soft-tissue pogonion. Using a black 
silk suture measurements were recorded in millimeters.
-Surgical procedure for extraction of impacted mandibu-
lar third molar:
Under routine aseptic precautions, local anesthesia was 
secured with 2% lignocaine hydrochloride with 1: 80,000 
adrenaline, using the conventional inferior alveolar nerve 
block. A standard Terrance-Ward incision was placed. A 
mucoperiosteal flap was raised exposing the underlying 
bone. Bone guttering was carried out buccally and on 
the distal aspect of the impacted tooth using a round bur. 
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Odontectomy was performed whenever indicated to fa-
cilitate tooth removal. The tooth was removed from the 
socket with the help of dental elevators. The socket was 
irrigated with povidine iodine and saline after the sharp 
bony edges were smoothened. Complete hemostasis was 
achieved and wound closed was obtained using 3-0 silk 
suture. The follow up was carried out on the 1st, 3rd 
and 5th post-operative day. All the patients were under 
standard antibiotic coverage with cap. amoxicillin 500 
mg thrice daily for 5 days postoperatively. 
The post-operative swelling, cheek girth and mouth ope-
ning were measured in the same manner as was done 
preoperatively. Pain assessment was made using subjec-
tive visual analog scale. Mouth opening was measured 
between the incisal edges of the maxillary and mandi-
bular central incisors. The data were statistically analy-
zed and interpreted by using un paired t – test and Chi-
square test.
Results
The present study was aimed at evaluating the indivi-
dual efficacies and comparing methylprednisolone 4mg 
orally and serratiopeptidase 10 mg orally in controlling 
post-operative pain, swelling and trismus after surgical 
removal of impacted mandibular third molars.
Time interval  Group 1 Group 2 Group 1  vs Group 2
t – value
Group 1  vs Group 2
p – value
Postoperative  Day -1 36.4 + 27.6 37.7 +24.9 0.25 0.80
Postoperative  Day -3 26.8 +38.4 16.8 +18.5 1.66 0.10
Postoperative  Day -5 10.2 +28.3 1.4 +8.2 2.11 < 0.05
Table 1. Comparison of post operative changes in swelling size between two groups.
Fig. 1. Comparison of changes in swelling measurements in two groups.
- Comparison of swelling size between two groups 
The mean size of the swelling in group I was 36.4 ± 
27.6, 26.8 ± 38.4 and  10.2 ± 28.3 on  day 1, 3 and 5 
respectively whereas in group II the mean size was 37.7 
± 24.9, 16.8 ± 18.5 and 1.4 ± 8.2  on  day 1, 3 and 5 
respectively. When compared, the results were statisti-
cally insignificant between group I and group II on the 
day 1 and 3 (p=0.80 and 0.10 respectively). However, 
statistical significance was observed on day 5. (Un pai-
red t–test). Thus, serratiopeptidase has better efficacy in 
controlling post-operative edema than methylpredniso-
lone (Table 1, Fig. 1).
- Comparison of pain between two groups on different 
days 
Under the mild pain category, group I had 5 patients re-
porting mild pain on day 1, 6 patients on day 3 and 22 
patients on day 5, whereas in group II, 1 patient reported 
mild pain on day 1  but no pain was reported on day 3 
(n=0) and 5 (n=0). Under the moderate pain category, 
group I had 9, 39 and 28 patients on day 1, 3 and 5 res-
pectively, whereas group II  had 1, 14 and 50 patients on 
day 1, 3 and 5 respectively. Under the severe pain cate-
gory, group I had 36  patients on day 1 and 5 patients on 
day 3 but no pain was reported on day 5 (n=0), whereas 
group II had 48 and 36 patients on day 1 and 3 respec-
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tively. No pain was reported on day 5 (n=0). These ob-
servations indicated statistically significant differences 
between the two groups (p<0.05), suggesting that pain 
control efficacy in group I was better than in group II 
(Chi-square test) (Table 2, Fig. 2).
- Comparison of changes in trismus between two groups 
The mean difference in mouth opening post-operatively on 
day 1 in group I was 17.7 ± 5.5mm; this difference reduced 
to 9.4 ± 4.0  and  1.3 ±  2.8 on day 3  and 5 respectively. The 
mean difference in mouth opening post-operatively on day 
1 in group II was 22.1 ±  4.2mm; this difference reduced to 
13.8 ± 5.6 and  8.3 ± 4.6 on day 3  and 5 respectively.
When the results were compared, statistical significance 
was observed between group I and II (P<0.001) i.e. re-
solution of trismus was better in group II than in group 
I. (Un paired t–test) This attests to the probable fact that 
serratiopeptidase is better than methylprednisolone in 
resolving trismus post-operatively (Table 3, Fig. 3).
Pain Post-op  D1 Post-op  D3 Post-op  D5
Group -1 n(%) Group -2 (%) Group -1 n(%) Group -2 (%) Group -1 n(%) Group -2 n(%)
Mild 5  (10) 1  (2) 6  (12) --- 22  (44) ---
Mod 9  (18) 1  (2) 39  (28) 14  (28) 28  (56) 50  (100)
Severe 36  (72) 48  (96) 5  (10) 36  (72) --- ---
Total 50 50 50 50 50 50
Group 1 vs 
Group 2
X2 =10.8 X2 =41.2 X2 =28.2
P < 0.05 P < 0.05 P < 0.05
Table 2. Comparison of postoperative pain between two groups on different days.
Fig. 2. Comparison of postoperative pain in two groups. 
Time interval  Group 1 Group 2 Group  1  vs Group 2
t - value
Group 1  vs Group 2
p – value
Post–op D -1 17.7 + 5.5 22.1 +4.2 4.50 < 0.001
Post–op D -3 9.4 +4.0 13.8 +5.6 4.52 < 0.001
Post–op D -5 1.3 +2.8 8.3 +4.6 9.19 < 0.001
Table 3. Comparison of changes in trismus between two groups.
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Fig. 3. Comparison of trismus measurement in two groups. 
Discussion
Surgical removal of impacted 3rd molar is usually percei-
ved as a procedure causing considerable pain and swe-
lling to the patient. Good surgical technique and gentle 
handling of tissues will minimize these symptoms. The 
body’s defense mechanism to cell injury is inflamma-
tion. When tissue damage occurs, large quantities of 
histamine, bradykinin, serotonin and other substances 
are released into the surrounding area (8,9). These subs-
tances, especially histamine causes local vasodilatation, 
thereby increasing blood flow to the damaged area. The 
permeability of venous capillaries and venules is also 
increased. This inflammatory process is necessary for 
healing to occur, but often excessive inflammation cau-
ses the patient unnecessary pain, swelling and trismus 
(10). Glucocorticosteroids are the group of steroids that 
possess anti-inflammatory properties secreted by the 
adrenal cortex (11). One of the most important actions 
of corticosteroids is the suppression of inflammation by 
interfering with capillary dilatation, edema formation, 
fibrin deposition, leucocytes migration and phagocyto-
sis (12,13). 
Enzymes are considered as extremely potent substances 
and the possibility of their therapeutic application is at-
tractive. Enzymes are derived from bacteria (streptoki-
nase and streptodornase), from plant (papase and bro-
melain) and from animals (trypsin and chymotrypsin). 
Serratiopeptidase is a proteolytic enzyme produced by 
a microorganism Serratia species. This endopeptidase 
is prepared from the culture broth of genus Serratio SP 
E-15 (one of the enteric bacilli in silk worm). It has high 
enzyme activity, including a potent anti-inflammatory 
action, anti-swelling as well as bradykinin-decomposing 
activity and it also enhances the antibiotic action at the 
site of the lesion (4,7).
Troullos et al. suggested that intravenous administration 
of methylprednisolone combined with low oral doses in 
effective management of postoperative surgical sequale. 
In our study, methylprednisolone 4 mg was administered 
orally for 5 days, which showed apparently good impro-
vement clinically (14).
Pederson concluded that steroid administration is effec-
tive in reducing post-operative complaints when pro-
nounced post-operative reaction can be expected and 
that short-term administration is safe in the absence of 
contraindications for such administration. In the present 
study, methylprednisolone was found to be safe in the 
absence of contraindications (15).
Panwar SK. concluded that a single preoperative dose of 
prednisolone reduces postoperative swelling. Statistical 
analysis and observations were done to determine the di-
fference in swelling, trismus and pain among the control 
group and study group. A single pre-operative dose of 
oral prednisolone helped the patient to cope the postope-
rative sequela, without causing major side effects. In our 
study, methylprednisolone 4 mg administered orally for 
5 days, showed good satisfactory results (16).
Esch et al. used serratiopeptidase for reduction of posto-
perative swelling in upper ankle joint surgery and con-
cluded that significant reduction in swelling had been 
achieved post- operatively with the use of serratiopepti-
dase. In the present study similar effects were observed 
with serratiopeptidase proving it to be better in reducing 
swelling than methylprednisolone (17).
Al-Khateeb and Nusair investigated the ability of serra-
tiopeptidase to reduce post-operative pain, swelling and 
trismus after third molar surgery. There was a significant 
reduction in the pain intensity and extent of cheek swe-
lling in the serratiopeptidase group at the 2nd, 3rd and 
7th post-operative days. The present study also indica-
ted similar results in which the serratiopeptidase group 
showed significantly reduced trismus and swelling on 
the day 1, 3 and 5 post-operatively. However, this en-
zyme preparation did not exert an appreciable analgesic 
effect post-operatively (7).
Murugesan K. found that dexamethasone was more 
effective in reducing  swelling and pain when compared 
with serratiopeptidase, however both had same effect 
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on trismus. In our study, serratiopeptidase 10 mg orally 
produced an appreciable anti-edema effect and had no 
apparent effect on rate of wound healing (18).
Conclusions
In the present study two different drugs methylpredniso-
lone  and serratiopeptidase were compared for clinical 
efficacy on post operative pain, swelling and trismus 
after surgical removal of mandibular third molars. Me-
thylprednisolone affords better pain relief while serra-
tiopeptidase exerts better anti-inflammatory effects in 
the post-operative period. Synergistic combinations of 
these two drugs would however prove to be more effec-
tive when extensive post-operative sequele are expected, 
but randomized case-control research trials need to be 
conducted in the future to attest to this probable fact.
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